The emerging function and clinical significance of circRNAs in Thyroid Cancer and Autoimmune Thyroid Diseases
- PMID: 33994857
- PMCID: PMC8120456
- DOI: 10.7150/ijbs.55381
The emerging function and clinical significance of circRNAs in Thyroid Cancer and Autoimmune Thyroid Diseases
Abstract
Thyroid cancer (TC) is one of the most common malignant tumors, with high morbidity and mortality rates worldwide. The incidence of TC, especially that of papillary thyroid carcinoma (PTC); has increased rapidly in recent decades. Autoimmune thyroid disease (AITD) is closely related to TC and has an estimated prevalence of 5%. Thus, it is becoming increasingly important to identify potential diagnostic biomarkers and therapeutic targets for TC and AITD. Circular RNAs (circRNAs) are a class of non-coding RNAs with covalently bonded circular structures that lack 5'-3' polarity and polyadenylated tails. Several circRNAs play crucial roles in the development of various diseases, including TC and AITD, and could be important new biomarkers and/or targets for the diagnosis and therapy of such disorders. Although there are four subtypes of TC, research on circRNA has largely focused on its connection to PTC. Therefore, this review mainly summarizes the relationships between circRNAs and PTC and AITD, including the molecular mechanisms underlying these relationships. In particular, the functions of "miRNA sponges" and their interactions with proteins and RNA are discussed. The possible targeting of circRNAs for the prevention, diagnosis, and treatment of TC and AITD is also described. CircRNAs could be potential biomarkers of TC and AITD, although validation will be required before they can be implemented in clinical practice.
Keywords: autoimmune thyroid diseases; biomarker; circular RNA; therapeutic target; thyroid cancer.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures



Similar articles
-
The Emerging Roles of circRNAs in Papillary Thyroid Carcinoma: Molecular Mechanisms and Biomarker Potential.Protein Pept Lett. 2023;30(9):709-718. doi: 10.2174/0929866530666230804104057. Protein Pept Lett. 2023. PMID: 37537939 Review.
-
Circular RNA profiling reveals a potential role of hsa_circ_IPCEF1 in papillary thyroid carcinoma.Mol Med Rep. 2021 Aug;24(2):603. doi: 10.3892/mmr.2021.12241. Epub 2021 Jun 24. Mol Med Rep. 2021. PMID: 34165176 Free PMC article.
-
Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression.Cell Death Dis. 2019 Feb 22;10(3):184. doi: 10.1038/s41419-019-1439-y. Cell Death Dis. 2019. PMID: 30796202 Free PMC article.
-
The emerging role and clinical significance of circRNAs in papillary thyroid cancer.Front Endocrinol (Lausanne). 2024 Mar 13;15:1351776. doi: 10.3389/fendo.2024.1351776. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38544689 Free PMC article. Review.
-
Emerging roles of circular RNAs in thyroid cancer.Exp Cell Res. 2021 Jul 15;404(2):112626. doi: 10.1016/j.yexcr.2021.112626. Epub 2021 May 21. Exp Cell Res. 2021. PMID: 34023393 Review.
Cited by
-
Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications.Front Oncol. 2022 Aug 17;12:951864. doi: 10.3389/fonc.2022.951864. eCollection 2022. Front Oncol. 2022. PMID: 36059609 Free PMC article. Review.
-
Doxorubicin-Induced Cardiotoxicity May Be Alleviated by Bone Marrow Mesenchymal Stem Cell-Derived Exosomal lncRNA via Inhibiting Inflammation.J Inflamm Res. 2022 Aug 6;15:4467-4486. doi: 10.2147/JIR.S358471. eCollection 2022. J Inflamm Res. 2022. PMID: 35966005 Free PMC article.
-
The LncRNA DUXAP10 Could Function as a Promising Oncogene in Human Cancer.Front Cell Dev Biol. 2022 Feb 3;10:832388. doi: 10.3389/fcell.2022.832388. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35186937 Free PMC article. Review.
-
Identification of GJC1 as a novel diagnostic marker for papillary thyroid carcinoma using weighted gene co-expression network analysis and machine learning algorithm.Discov Oncol. 2025 Mar 17;16(1):339. doi: 10.1007/s12672-025-02137-7. Discov Oncol. 2025. PMID: 40095160 Free PMC article.
-
FADD as a key molecular player in cancer progression.Mol Med. 2022 Nov 8;28(1):132. doi: 10.1186/s10020-022-00560-y. Mol Med. 2022. PMID: 36348274 Free PMC article. Review.
References
-
- Frazell EL, Foote FW Jr. The natural history of thyroid cancer; a review of 301 cases. J Clin Endocrinol Metab. 1949;9:1023–30. - PubMed
-
- Nikiforov YE, Nikiforova MN. Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol. 2011;7:569–80. - PubMed
-
- Kondo T, Ezzat S, Asa SL. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer. 2006;6:292–306. - PubMed
-
- Takano T. Natural history of thyroid cancer. Endocr J. 2017;64:237–44. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical